Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Method-for-measuring-no-synthase-activity

 Rapid production of autologous tumor vaccines
In accordance with the present invention an autologous vaccine to tumor cells is produced by ...


 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
OF THE INVENTION In accordance with the invention novel therapeutic use is provided for certain ...


 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
OF THE INVENTION Inhibition of Engineered Kinases FIG. 9 shows a schematic representation of an ...


 Method for the production of bacterial toxins
The present invention is based upon the discovery that bacterial toxin expression inhibitors ...


 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
OF PREFERRED EMBODIMENTS In its preferred embodiments, this invention involves preparation and ...


 Modified protein kinase A-specific oligonucleotides and methods of their use
The present invention relates to modified oligonucleotides useful for studies of gene expression ...


 Peptides and nucleic acid sequences related to the Epstein Barr virus
OF THE INVENTION The term "peptide" as used herein refers to a molecular chain of amino acids with ...


 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
The present invention provides a method of optimizing therapeutic efficacy of 6-mercaptopurine drug ...


 Production of peptides in plants as viral coat protein fusions
What is claimed is: 1. A virion particle comprising a coat protein of a Tobamovirus and a fusion ...


 Macrolide antibiotics
OF THE INVENTION The following reaction Schemes illustrate the preparation of the compounds of the ...


 Method for measuring no synthase activity

Details
Inventors: Hennies, Hagen-Heinrich; Sundermann, Bernd;
Assignee: Gruenenthal GmbH (Aachen, DE)
Primary Examiner: Grunberg; Anne Marie
Assistant Examiner: Hwu; June
Attorney, Agent or Firm: Crowell & Moring LLP

A method for measuring the activity of NO-synthase, a corresponding method for identification of NO-synthase modulators, in particular for application in a HTS (High Throughput Screening) and use of the corresponding cation-exchange filter-plate membranes.

DETAILED DESCRIPTION OF THE INVENTION In the context of the present invention the following definitions apply: Incubation: the introduction and leaving of a biological object, such as an enzyme, NOS, in a medium to which, possibly, further compounds are or have been added, such as the enzyme substrate.
For this incubation appropriate (usually similar to physiological) conditions are chosen, in order to achieve a certain effect.
For example, an enzyme reaction takes place, e.
g.
, the conversion of arginine into citrulline and NO catalyzed by NOS.
The conditions are achieved, for example, by controlling the temperature, pH, coenzymes or cofactors and/or reaction time etc.
Reaction vessel: a vessel in which a chemical reaction, or a separation based on bonding or other physical forces, can take its course under controlled conditions.
Examples include an Eppendorf cup, a culture dish or flask, a test tube, a centrifuge tube or a well of a microtiter plate.
A reaction vessel may be divided into compartments by selectively permeable membranes.
It does not necessarily have to be sealed so that fluids cannot pass through, not even on the underside of the vessel.
Thus reaction vessels can be columns or microtiter plates also sealed on one side (usually the underside) by a selectively permeable membrane, such as a filter-plate membrane.
The incubation (step a), and preferably also the separation (step b), takes place in a reaction vessel.
Separation: by this the spatial separation of arginine from citrulline is understood, so that, unlike the incubation mixture which contains both substances homogeneously in a certain proportion, separate areas are formed so that the arginine is almost completely confined in one area and the citrulline has almost been completely removed in comparison to the previous concentration, and in an other area the opposite is the case.
The separation can, for example, be effected physically by means of size or molecular weight filters, by means of charging (cation exchangers, chromatographically or by applying voltage), or, for example, by centrifugation



Related patents
  Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
In one aspect, the present invention pertains to the discovery herein that Wnt polypeptides ("Wnts"), such as Wnt-5a, play a role in hematopoiesis. In another aspect, ...
  Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
The invention relates to a composition for delivery of a virus vector to an animal cell. The composition comprises a hydrogel precursor mixture having the virus vector ...
  Particle delivery techniques
OF THE PREFERRED EMBODIMENTS The practice of the present invention will employ, unless otherwise indicated, conventional methods of molecular biology and recombinant DNA...
  Tissue anchor system
The invention claimed is: 1. An adjustable tissue anchor comprising: a. an anchor body having a first and second open end with an interior chamber running between said ...
  Ribozyme mediated inactivation of the androgen receptor
The present invention describes inactivation of AR gene expression by engineering hammerhead ribozymes to cleave specific sites in AR mRNA. The present in vitro studies ...
  Thyrotropin-releasing hormone analogues and their therapeutic applications
The present invention pertains to novel TRH analogues, compositions, and methods for the controlled administration of novel TRH analogues to mammals. The present ...
  Probiotics in primary prevention of atopic diseases
What is claimed is: 1. A method for prevention of atopic diseases selected from the group consisting of atopic eczema, allergic rhinitis and asthma in an infant at high ...
  Humanin-like peptide and use thereof
The invention claimed is: 1. A polypeptide comprising an amino acid sequence as shown in SEQ ID NO: 4, or an amide, ester or salt thereof. 2. The polypeptide according ...
  Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
The invention claimed is: 1. A method for treating a cancer patient who is undergoing or has undergone a radiation therapy or chemotherapy treatment, the method ...
  Method of treating cardiovascular diseases
OF PREFERRED EMBODIMENTS As examples of the diseases which the method according to the invention is useful to prevent or alleviate, there are mentioned eye diseases ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved